Show simple item record

dc.contributor.authorOmlin, A
dc.contributor.authorJones, R
dc.contributor.authorvan der Noll, R
dc.contributor.authorSatoh, T
dc.contributor.authorNiwakawa, M
dc.contributor.authorSmith, S A
dc.contributor.authorGraham, J
dc.contributor.authorOng, M
dc.contributor.authorFinkelman, R
dc.contributor.authorSchellens, J
dc.contributor.authorZivi, A
dc.contributor.authorCrespo, M
dc.contributor.authorRiisnaes, R
dc.contributor.authorNava Rodrigues, D
dc.contributor.authorMalone, Malcolm D
dc.contributor.authorDive, Caroline
dc.contributor.authorSloane, Robert
dc.contributor.authorMoore, David
dc.contributor.authorAlumkal, J
dc.contributor.authorDymond, A
dc.contributor.authorDickinson, P
dc.contributor.authorRanson, M
dc.contributor.authorClack, G
dc.contributor.authorde Bono, J
dc.contributor.authorElliott, Tony
dc.date.accessioned2015-07-21T10:30:49Zen
dc.date.available2015-07-21T10:30:49Zen
dc.date.issued2015-06en
dc.identifier.citationAZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies. 2015, 33 (3):679-90 Invest New Drugsen
dc.identifier.issn1573-0646en
dc.identifier.pmid25920479en
dc.identifier.doi10.1007/s10637-015-0235-5en
dc.identifier.urihttp://hdl.handle.net/10541/560760en
dc.description.abstractAZD3514 is a first-in-class, orally bio-available, androgen-dependent and -independent androgen receptor inhibitor and selective androgen-receptor down-regulator (SARD).
dc.language.isoenen
dc.rightsArchived with thanks to Investigational new drugsen
dc.titleAZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies.en
dc.typeArticleen
dc.contributor.departmentProstate Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UKen
dc.identifier.journalInvestigational New Drugsen
html.description.abstractAZD3514 is a first-in-class, orally bio-available, androgen-dependent and -independent androgen receptor inhibitor and selective androgen-receptor down-regulator (SARD).


This item appears in the following Collection(s)

Show simple item record